Trials / Recruiting
RecruitingNCT07361289
A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
A Single-Arm Observational Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the effectiveness of mavacamten treatment in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM) in real-world clinical practice
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mavacamten | According to the product label |
Timeline
- Start date
- 2026-01-15
- Primary completion
- 2028-08-22
- Completion
- 2028-08-28
- First posted
- 2026-01-23
- Last updated
- 2026-04-13
Locations
15 sites across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07361289. Inclusion in this directory is not an endorsement.